Previous 10 | Next 10 |
Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced the appointments of Adrienne Graves, Ph.D., and Lauren Silvernail to the Company’s Board of Directors, effective immediately. Harrow’s Board now consists of six members. “I am deligh...
2024-01-19 13:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-01-11 10:34:40 ET More on Harrow Health Despite Q3 Earnings Miss, Harrow Is Still Appealing For 2024 Harrow, Inc. (HROW) Q3 2023 Earnings Call Transcript Implications Of Harrow's Short-Term Guidance Harrow stock tumbles 38% in wake of Q3 report, revised ...
VEVYE® Offers Rapid Onset with Clinically and Statistically Meaningful Improvement Beginning as Early as 15 Days 1 with Sustained Improvement over 56 Weeks 2 VEVYE® Patients to Have Access to a 100% Money-Back Guarantee Program 3 Harrow (Nasdaq: HRO...
Melt Pharmaceuticals, Inc. (“Melt”), a clinical‑stage pharmaceutical company developing novel approaches for procedural sedation, today provided a corporate update. The Company previously announced that MELT-300 achieved the primary sedation endpoint in its Phase 2 Pivota...
Agreements Support the Upcoming Launch of VEVYE ® Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced that it has partnered with three leading healthcare technology platforms to expand U.S. availability of VEVYE ® (cyclosporine ophthal...
2024-01-02 07:09:05 ET Summary The Bloomberg report alleging an investigation into Franchise Group, Inc. (FRG)'s CEO relates to a fraud case against one of his associates from a previous employment, unlikely to impact RILY or FRG. Management is committed to its $1 quarterly distri...
2023-12-24 13:08:45 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips While the concept of short-squeeze stocks has been all the rage throughout most of the pandemic-disruption cycle, we may have been doing this all wrong. Rather, it’s time to address this...
2023-12-13 02:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced the completion of the transfer to Harrow of the New Drug Application (NDA) for TRIESENCE ® (triamcinolone acetonide injectable suspension) 40 mg/mL, a synthetic corticosteroid indicated for the treatmen...
News, Short Squeeze, Breakout and More Instantly...
2024-06-21 10:00:07 ET Chase Knickerbocker from Craig-Hallum issued a price target of $30.00 for HROW on 2024-06-21 08:28:00. The adjusted price target was set to $30.00. At the time of the announcement, HROW was trading at $19.93. The overall price target consensus is a...
Harrow Health, Inc. (NASDAQ: HROW) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 13.77% on the day to $20.08. Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an op...